Patent details

Basic Information

Publication number:

EP3337486

PCT Application Number:

US2016048054

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168399426

PCT Publication Number:

WO2017035077

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEUTERATED COMPOUNDS AND USES THEREOF

French Title of Invention:

COMPOSÉS DEUTÉRÉS ET LEURS UTILISATIONS

German Title of Invention:

DEUTERIERTE VERBINDUNGEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

22/08/2016

Grant date:

03/04/2024

EP Publication Date:

27/06/2018

PCT Publication Date:

02/03/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/04/2024

EP B1 Publication Date:

03/04/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/08/2024

Expiration date:

22/08/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/03/2024

 

 

Name:

Aldeyra Therapeutics, Inc.

Address:

131 Hartwell Avenue Suite 320, Lexington, MA 02421, United States (US)

Inventor

1

Name:

BRADY, Todd

Address:

United States (US)

2

Name:

YOUNG, Scott

Address:

United States (US)

3

Name:

KINNEY, William, A.

Address:

United States (US)

4

Name:

MACDONALD, Susan

Address:

United States (US)

Priority

Priority Number:

201562208223 P

Priority Date:

21/08/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; A61P 39/00; A61P 17/00; C07D 215/38; A61P 27/02;

Publication

European Patent Bulletin

Issue number:

202414

Publication date:

03/04/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages